Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-11-010589)

Filing Details

Accession Number:: 0001140361-11-010589
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-17 19:53:00
Reporting Period:: 2011-02-15

Filing Date:: 2011-02-17
Accepted Time:: 2011-02-17 19:53:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1261734	Aeolus Pharmaceuticals Inc.	AOLS	Pharmaceutical Preparations (2834)	561953785

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1350855	Efficacy Capital, Ltd.	11622 El Camino Real, Suite 100 San Deigo CA 92130		No	No	Yes	No
1366070	Ltd. Fund Master Biotech Efficacy	11622 El Camino Real Suite 100 San Diego CA 92130		No	No	Yes	No
1366071	Ltd Fund Biotech Efficacy	11622 El Camino Real Suite 100 San Diego CA 92130		No	No	Yes	No
1366073	L.p. Fund Biotech Efficacy	11622 El Camino Real Suite 100 San Diego CA 92130		No	No	Yes	No
1366074	Mark Lappe	11622 El Camino Real Suite 100 San Diego CA 92130		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-02-15	7,000	$0.95	8,399,646	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2011-02-16	57,600	$0.97	8,342,046	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

These shares are owned directly by Efficacy Biotech Master Fund Ltd. The Reporting Company acts as an investment advisor with investment and voting discretion over portfolio investments. The Reporting Company is an indirect beneficial owner of the reported securities.